Published in Proc Natl Acad Sci U S A on April 24, 2001
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev (2006) 6.39
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A (2003) 2.88
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol (2008) 1.98
Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol (2002) 1.53
Importance of prophages to evolution and virulence of bacterial pathogens. Virulence (2013) 1.48
Integration of metabolism and virulence by Clostridium difficile CodY. J Bacteriol (2010) 1.43
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. J Clin Microbiol (2011) 1.37
A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein. Mol Microbiol (2009) 1.30
The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol (2011) 1.30
Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile. PLoS One (2011) 1.29
FlhA influences Bacillus thuringiensis PlcR-regulated gene transcription, protein production, and virulence. Appl Environ Microbiol (2005) 1.28
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes (2010) 1.19
Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol (2014) 1.16
Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog (2012) 1.12
Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J Bacteriol (2011) 1.10
Proline-dependent regulation of Clostridium difficile Stickland metabolism. J Bacteriol (2012) 1.09
Bacteriophage-mediated toxin gene regulation in Clostridium difficile. J Virol (2009) 1.09
Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes (2011) 1.06
TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm. PLoS One (2012) 1.02
Evidence that Clostridium difficile TcdC is a membrane-associated protein. J Bacteriol (2006) 1.00
The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J Bacteriol (2013) 1.00
Clostridium difficile infection. Nat Rev Dis Prim (2016) 0.99
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR. J Clin Microbiol (2008) 0.96
Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect Immun (2003) 0.96
Insights from the architecture of the bacterial transcription apparatus. J Struct Biol (2011) 0.95
Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev (2015) 0.94
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol (2015) 0.93
Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genomics (2014) 0.93
Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect Immun (2012) 0.92
Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther (2014) 0.92
Integration of metabolism and virulence in Clostridium difficile. Res Microbiol (2014) 0.92
CodY-Dependent Regulation of Sporulation in Clostridium difficile. J Bacteriol (2016) 0.92
Toxin synthesis by Clostridium difficile is regulated through quorum signaling. MBio (2015) 0.91
Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C. J Bacteriol (2009) 0.91
Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile. J Bacteriol (2014) 0.91
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol (2016) 0.90
Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR. PLoS One (2013) 0.89
Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus. Sci Rep (2015) 0.88
RhuR, an extracytoplasmic function sigma factor activator, is essential for heme-dependent expression of the outer membrane heme and hemoprotein receptor of Bordetella avium. Infect Immun (2004) 0.88
Positive regulation of botulinum neurotoxin gene expression by CodY in Clostridium botulinum ATCC 3502. Appl Environ Microbiol (2014) 0.87
Two-component signal transduction system CBO0787/CBO0786 represses transcription from botulinum neurotoxin promoters in Clostridium botulinum ATCC 3502. PLoS Pathog (2013) 0.87
Clostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection. Infect Immun (2014) 0.86
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen. Gut Microbes (2014) 0.86
Identification and characterization of Clostridium sordellii toxin gene regulator. J Bacteriol (2013) 0.85
A novel regulator controls Clostridium difficile sporulation, motility and toxin production. Mol Microbiol (2016) 0.85
The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes (2014) 0.84
Isolation of RNA polymerase from Clostridium difficile and characterization of glutamate dehydrogenase and rRNA gene promoters in vitro and in vivo. J Bacteriol (2006) 0.82
Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures. Nucleic Acids Res (2013) 0.82
Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests. Proc Natl Acad Sci U S A (2009) 0.82
Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits. Comp Med (2010) 0.82
The SOS Response Master Regulator LexA Is Associated with Sporulation, Motility and Biofilm Formation in Clostridium difficile. PLoS One (2015) 0.81
In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119. Anaerobe (2011) 0.81
Mobile genetic elements in Clostridium difficile and their role in genome function. Res Microbiol (2015) 0.80
Mathematical modelling reveals properties of TcdC required for it to be a negative regulator of toxin production in Clostridium difficile. J Math Biol (2014) 0.79
Time-resolved amino acid uptake of Clostridium difficile 630Δerm and concomitant fermentation product and toxin formation. BMC Microbiol (2015) 0.79
Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion. J Bacteriol (2015) 0.78
Increased toxin expression in a Clostridium difficile mfd mutant. BMC Microbiol (2015) 0.78
The Regulatory Networks That Control Clostridium difficile Toxin Synthesis. Toxins (Basel) (2016) 0.78
Cyclic diguanylate signaling in Gram-positive bacteria. FEMS Microbiol Rev (2016) 0.77
Control of Clostridium difficile Physiopathology in Response to Cysteine Availability. Infect Immun (2016) 0.77
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel) (2016) 0.77
The HtrA-like protease CD3284 modulates virulence of Clostridium difficile. Infect Immun (2014) 0.77
The bacterial DNA repair protein Mfd confers resistance to the host nitrogen immune response. Sci Rep (2016) 0.76
The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile. Infect Immun (2016) 0.75
Effect of tcdR Mutation on Sporulation in the Epidemic Clostridium difficile Strain R20291. mSphere (2017) 0.75
A genetic switch controls the production of flagella and toxins in Clostridium difficile. PLoS Genet (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Res (1983) 38.72
Plasmids for ectopic integration in Bacillus subtilis. Gene (1996) 5.87
Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase sigma factors involved in the regulation of extracytoplasmic functions. Proc Natl Acad Sci U S A (1994) 4.89
Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol Rev (1991) 3.81
Clostridium difficile infection. Annu Rev Med (1998) 3.63
The extracytoplasmic function sigma factors: role and regulation. Mol Microbiol (1998) 3.13
The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem (1995) 3.02
Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene (1996) 2.87
Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol (1996) 2.85
The response of Pseudomonas aeruginosa to iron: genetics, biochemistry and virulence. Mol Microbiol (1999) 2.70
The algT (algU) gene of Pseudomonas aeruginosa, a key regulator involved in alginate biosynthesis, encodes an alternative sigma factor (sigma E). Proc Natl Acad Sci U S A (1995) 2.42
High- and low-copy-number Lactococcus shuttle cloning vectors with features for clone screening. Gene (1993) 2.35
Clostridium perfringens-Escherichia coli shuttle vectors that carry single antibiotic resistance determinants. Plasmid (1993) 2.35
Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol (1998) 2.28
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25
Identification and characterization of sporulation-dependent promoters upstream of the enterotoxin gene (cpe) of Clostridium perfringens. J Bacteriol (1998) 2.02
The toxigenic element of Clostridium difficile strain VPI 10463. Microb Pathog (1995) 1.89
Studies of UV-inducible promoters from Clostridium perfringens in vivo and in vitro. Mol Microbiol (1988) 1.72
Exotoxin A production in Pseudomonas aeruginosa requires the iron-regulated pvdS gene encoding an alternative sigma factor. Mol Microbiol (1996) 1.65
Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology (1999) 1.61
Mechanism of initiation of transcription by Bacillus subtilis RNA polymerase at several promoters. J Mol Biol (1992) 1.51
Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis (2000) 1.47
CcpC, a novel regulator of the LysR family required for glucose repression of the citB gene in Bacillus subtilis. J Mol Biol (2000) 1.45
Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun (1995) 1.26
botR/A is a positive regulator of botulinum neurotoxin and associated non-toxin protein genes in Clostridium botulinum A. Mol Microbiol (1998) 1.25
Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun (2000) 1.23
TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect Immun (1998) 1.20
Positive regulation of Clostridium difficile toxins. Infect Immun (1997) 1.17
The pvc gene cluster of Pseudomonas aeruginosa: role in synthesis of the pyoverdine chromophore and regulation by PtxR and PvdS. J Bacteriol (1999) 1.14
Iron-responsive gene expression in Pseudomonas fluorescens M114: cloning and characterization of a transcription-activating factor, PbrA. Mol Microbiol (1995) 1.03
Toxin production by Clostridium difficile in a defined medium with limited amino acids. J Med Microbiol (1994) 1.00
Effect of arginine on toxin production by Clostridium difficile in defined medium. Microbiol Immunol (1997) 0.98
Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentralbl Bakteriol (1998) 0.95
Inhibition of enhanced toxin production by Clostridium difficile in biotin-limited conditions. J Med Microbiol (1998) 0.91
Clostridium difficile toxins attack Rho. Trends Microbiol (1996) 0.91
Effect of clindamycin on cytotoxin production by Clostridium difficile. Microbiol Immunol (1982) 0.89
ToxR (RegA)-mediated in vitro transcription of Pseudomonas aeruginosa toxA. Gene (1994) 0.86
Genome mapping of Clostridium perfringens strains with I-CeuI shows many virulence genes to be plasmid-borne. Mol Gen Genet (1996) 1.74
An enzyme with type IV prepilin peptidase activity is required to process components of the general extracellular protein secretion pathway of Klebsiella oxytoca. Mol Microbiol (1992) 1.58
Nitrous oxide anesthesia-associated myelopathy. Arch Neurol (2000) 1.40
Control of pilus expression in Neisseria gonorrhoeae as an original system in the family of two-component regulators. Mol Microbiol (1991) 1.24
Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett (1999) 1.16
Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 0.96
Rapid expansion of the physical and genetic map of the chromosome of Clostridium perfringens CPN50. J Bacteriol (1995) 0.94
Evaluation of proliferation and protein expression of human bone marrow cells cultured on coral crystallized in the aragonite of calcite form. J Biomed Mater Res (1998) 0.92
Lack of responsiveness to glucose of microencapsulated islets of Langerhans after three weeks' implantation in the rat--influence of the complement. J Microencapsul (1990) 0.91
Evolution of the local calcium content around irradiated beta-tricalcium phosphate ceramic implants: in vivo study in the rabbit. Biomaterials (1998) 0.91
[Neurologic forms of Lyme disease. 12 cases]. Rev Neurol (Paris) (1989) 0.88
Considerations from the European DNA profiling group (EDNAP) concerning STR nomenclature. Forensic Sci Int (1997) 0.86
Polymorphonuclear cell apoptosis in exudates generated by polymers. J Biomed Mater Res (1999) 0.86
Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci (1993) 0.84
Biocompatibility of polyacrylamide microcapsules implanted in peritoneal cavity or spleen of the rat. Effect on various inflammatory reactions in vitro. Biomater Artif Cells Artif Organs (1990) 0.83
Role of pilA, an essential regulatory gene of Neisseria gonorrhoeae, in the stress response. J Bacteriol (1992) 0.82
Influence of the structure of three corals on their resorption kinetics. J Periodontal Res (1996) 0.81
Cellular biocompatibility and resistance to compression of macroporous beta-tricalcium phosphate ceramics. Biomaterials (1998) 0.80
Encapsulation of calcitonin in liposomes depends on the vesicle preparation method. J Microencapsul (1998) 0.80
Agarose encapsulation of islets of Langerhans: reduced toxicity in vitro. J Microencapsul (1989) 0.80
Calcitonin-loaded liposomes: stability under acidic conditions and bile salts-induced disruption resulting in calcitonin-phospholipid complex formation. Biochim Biophys Acta (1994) 0.79
Rationale for the design of biomaterials and the evaluation of their biocompatibility. Biorheology (1991) 0.79
Study of a (trimethylenecarbonate-co-epsilon-caprolactone) polymer--part 2: in vitro cytocompatibility analysis and in vivo ED1 cell response of a new nerve guide. Biomaterials (2001) 0.78
Quantification of the inflammatory response in exudates to three polymers implanted in vivo. J Biomed Mater Res (1998) 0.77
Hemodynamic study of internal carotid artery stenosis and occlusion: value of combined isotopic measurements of regional cerebral blood flow and blood volume. Ann Vasc Surg (1986) 0.77
Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism. Arch Intern Med (1987) 0.77
The resorption of bone-implanted corals varies with porosity but also with the host reaction. J Biomed Mater Res (1995) 0.76
Tryptophan and neutral amino acid concentrations in serum of rats after salmon calcitonin injection. Experientia (1983) 0.76
In vitro culture of hybridoma cells in agarose beads producing antibody secretion for two weeks. Biotechnol Bioeng (1992) 0.76
Reproducibility of mtDNA analysis between laboratories: a report of the European DNA Profiling Group (EDNAP). Forensic Sci Int (1998) 0.75
Plasma nanotextured polymeric lab-on-a-chip for highly efficient bacteria capture and lysis. Lab Chip (2015) 0.75
Immunoprotection obtained with microcapsules does not prevent cytotoxicity of small inflammatory mediators. Horm Metab Res (1992) 0.75
[Some comments on the biological properties of calcitonin: an eventual new therapeutic utilization (author's transl)]. Ann Endocrinol (Paris) (1977) 0.75
[In vitro study of the cytotoxicity of inflammation mediators secreted around microencapsulated cells]. C R Seances Soc Biol Fil (1991) 0.75
[Preservation of the functional integrity of cellular material after cell microencapsulation by polymerization]. C R Seances Soc Biol Fil (1988) 0.75
[Recurrent cerebral vascular complications connected with Methergine in obstetrics]. Rev Otoneuroophtalmol (1980) 0.75
[The localization of calcium in the rat thyroid]. C R Seances Soc Biol Fil (1976) 0.75
[Accidental poisoning with podophyllin: a case with study of peripheral nerve]. Rev Neurol (Paris) (1991) 0.75
"In vitro" dissolution of coral in peritoneal or fibroblast cell cultures. J Dent Res (1998) 0.75
Lithium effect on calcitonin secretion in the rat. Biomedicine (1980) 0.75
[Testicular biospy in electron microscopy]. Rev Fr Endocrinol Clin (1972) 0.75
[Neuropathies caused by thalidomide]. Rev Neurol (Paris) (1985) 0.75
[Accuracy and reproducibility of Nidek's photokeratoanalyser]. J Fr Ophtalmol (1991) 0.75
[Peripheral nerves in a case of lead neuropathy]. Rev Neurol (Paris) (1984) 0.75
Neural activity from the acutely infected HSV-1 rabbit cornea. Curr Eye Res (1988) 0.75
[Histochemical localization of calcium in the colloid of rat thyroid vesicles (author's transl)]. Calcif Tissue Res (1977) 0.75
[Effect of porcine calcitonin on human blood platelet aggregation in vitro]. C R Seances Soc Biol Fil (1978) 0.75
Antistress effects of calcitonin. Biomed Pharmacother (1983) 0.75
Peritoneal exudates from microencapsulated rat islets of Langerhans xenografted mice presenting characteristics of potentially cytotoxic non-specific inflammation. J Microencapsul (1992) 0.75
Report of the European DNA profiling group (EDNAP): an investigation of the complex STR loci D21S11 and HUMFIBRA (FGA). Forensic Sci Int (1997) 0.75
[Hemodynamic study of obstructive lesions of the internal carotid artery: value of coupled measurement of regional cerebral blood flow and volume]. Rev Neurol (Paris) (1987) 0.75
A two-step embedding process for better preservation of soft tissue surrounding coral implants. J Biomed Mater Res (1996) 0.75
[Meige's syndrome (author's transl)]. Rev Otoneuroophtalmol (1981) 0.75
Cholate-induced disruption of calcitonin-loaded liposomes: formation of trypsin-resistant lipid-calcitonin-cholate complexes. Pharm Res (1995) 0.75
Association of polyacrylamide beads to polyethylene terephthalate prostheses. Biomater Artif Cells Immobilization Biotechnol (1993) 0.75
[Research on calcitonin synthesis and secretion]. C R Seances Soc Biol Fil (1974) 0.75
[Lyme disease manifested by polyradiculoneuritis without hypercytosis of the cerebrospinal fluid]. Presse Med (1988) 0.75
[Accuracy and reproducibility of the Eyesys corneal topographic analysis system]. J Fr Ophtalmol (1994) 0.75
[Transient neonatal endocrine disorders: an hypothesis about the role of calcitonin in some neonatal hypocalcemia (author's transl)]. Ann Endocrinol (Paris) (1979) 0.75
[Effect of ethanol on the secretion of calcitonin in the rat]. C R Seances Acad Sci III (1981) 0.75
[Qualitative evaluation of the number of granulations of parafollicular cells of the rat thyroid]. C R Seances Soc Biol Fil (1973) 0.75
Orally administered liposomes prepared with egg phosphatidylcholine and stearylamine: possible destruction in rat intestinal wall. Horm Metab Res (1992) 0.75
Theory for shock dynamics in particle-laden thin films. Phys Rev Lett (2005) 0.75
Embedded adrenal cells graft reduced local and early nonspecific inflammatory phenomena which follow agarose beads implantation. Cell Transplant (1992) 0.75
[Multimodal or multisensorial agnosia?]. Rev Neurol (Paris) (1994) 0.75
Identification of immunoreactive calcitonin granulations in para-follicular like cells in the neighbourhood of the colloid in the hypercalcemic rats thyroid. Biomed Pharmacother (1982) 0.75
In vitro diffusion in polyacrylamide embedded agarose microbeads. J Microencapsul (1990) 0.75
Report of the European DNA Profiling Group (EDNAP)--an investigation of the hypervariable STR loci ACTBP2, APOAI1 and D11S554 and the compound loci D12S391 and D1S1656. Forensic Sci Int (1998) 0.75
[Structural and functional variations of the C cells during experimental hypothyroidism in the rat]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.75
[Biocompatibility of hydroxypropylmethylcellulose as a vitreous substitute in rabbits]. Ophtalmologie (1991) 0.75